Pages that link to "Q45016875"

The following pages link to Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study (Q45016875):

Displaying 39 items.

• Statin Therapy in Metabolic Syndrome and Hypertension Post-JUPITER: What is the Value of CRP? (Q24602803) (← links)
• Population health needs assessment and healthcare services use in a 3 years follow-up on administrative and clinical data: results from the Brisighella Heart Study (Q30696589) (← links)
• Long-Term Effects of Xuezhikang on Blood Pressure in Hypertensive Patients with Previous Myocardial Infarction: Data from the Chinese Coronary Secondary Prevention Study (CCSPS) (Q33751578) (← links)
• Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial (Q33754137) (← links)
• Influence of dyslipidemia in control of arterial hypertension among type-2 diabetics in the western region of the Republic of Macedonia (Q33847033) (← links)
• Relaxation of rat thoracic aorta by fibrate drugs correlates with their potency to disturb intracellular calcium of VSMCs (Q34143658) (← links)
• Omega-3 polyunsaturated fatty acids: Their potential role in blood pressure prevention and management (Q35252642) (← links)
• LIPITENSION: Interplay between dyslipidemia and hypertension (Q35856063) (← links)
• Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study (Q35993667) (← links)
• Use of statins and blood pressure. (Q36092447) (← links)
• Probiotics Blunt the Anti-Hypertensive Effect of Blueberry Feeding in Hypertensive Rats without Altering Hippuric Acid Production (Q36257682) (← links)
• Statins: another class of antihypertensive agents? (Q36411099) (← links)
• Changes in lipids and lipoprotein indices in relation to the severity of hypertension in newly diagnosed hypertensive nigerians (Q36488798) (← links)
• Analysis of antihypertensive effects of statins. (Q36829002) (← links)
• Statins and blood pressure: is there an effect or not? (Q36836591) (← links)
• Do statins lower blood pressure? (Q36847085) (← links)
• Are statins effective for simultaneously treating dyslipidemias and hypertension? (Q36896062) (← links)
• Simvastatin induces a central hypotensive effect via Ras-mediated signalling to cause eNOS up-regulation (Q37237168) (← links)
• Dyslipidaemia as a predictor of hypertension in middle-aged men. (Q37291520) (← links)
• Current role of statins in the treatment of essential hypertension (Q37760221) (← links)
• Does the blood pressure-lowering effect of statins contribute to their beneficial cardiovascular effects? (Q37763196) (← links)
• Hypertension: management perspectives (Q38026885) (← links)
• The antihypertensive actions of statins: modulation by salt intake (Q38029526) (← links)
• The effects of red yeast rice dietary supplement on blood pressure, lipid profile, and C-reactive protein in hypertension: A systematic review (Q38388529) (← links)
• PPARα-dependent increase of mouse urine output by gemfibrozil and fenofibrate. (Q39130668) (← links)
• The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension (Q39197925) (← links)
• Factors associated with therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia (Q39202869) (← links)
• Membrane tension modulates the effects of apical cholesterol on the renal epithelial sodium channel (Q40064133) (← links)
• Hypotensive effect of atorvastatin in hypertensive patients: the association among flow-mediated dilation, oxidative stress and endothelial dysfunction (Q40623951) (← links)
• Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways (Q41880179) (← links)
• Hypotensive effect of atorvastatin is not related to changes in inflammation and oxidative stress (Q42794524) (← links)
• Hyperlipidaemia and its risk factors in the Guangxi Bai Ku Yao and Han populations (Q43457807) (← links)
• Antihypertensive drug class and dyslipidemia: risk association among Chinese patients with uncomplicated hypertension (Q46570226) (← links)
• Prevalence of hyperlipidemia and its risk factors for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han populations (Q51774303) (← links)
• Evaluation of lipid profile and its relationship with blood pressure in patients with Cushing's disease. (Q52721054) (← links)
• Rate of control of LDL cholesterol and incident hypertension requiring antihypertensive treatment in hypercholesterolemic subjects in daily clinical practice (Q56975107) (← links)
• Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study (Q56989356) (← links)
• Effect of pravastatin on blood pressure in people with cardiovascular disease (Q63681912) (← links)
• Blood pressure-lowering effect of simvastatin: a placebo-controlled randomized clinical trial with 24-h ambulatory blood pressure monitoring (Q86802923) (← links)